Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Jennifer Kim
CANT
Jennifer Kim
Cantor Fitzgerald
Wall Street Analyst
★★★☆☆
#842
on 13Foresight · ranked by our own returns
78%
Success Rate
+31.9%
Average Return
7 of 9 calls profitable · +11.2% vs benchmark
🔒 5-year track record is Pro. Showing 1-year — upgrade.
📈 Across the calls we could measure, roughly 78% of Jennifer Kim's ratings turned a profit when each position was held for 1 year — averaging +31.9% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

2 Buy 0 Hold 0 Sell
Jennifer's Stock Coverage 11 ratings · 2026-06-19
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return
PGEN
Precigen
 Sep 26, 2025 BUY Buy
+404.8% avg upside
11 analysts
 — +34.8%
BLTE
Belite Bio, Inc. ADR
 May 15, 2025 BUY Strong Buy
+25.0% avg upside
10 analysts
 — +113.2%
INSM
Insmed
 Apr 11, 2025 BUY Strong Buy
+82.1% avg upside
36 analysts
 — +125.8%
EYPT
EyePoint Pharmaceuticals
 Feb 05, 2025 BUY Strong Buy
+124.1% avg upside
17 analysts
 — +63.2%
FBIO
Fortress Biotech
 Aug 14, 2023 BUY Strong Buy
+163.3% avg upside
12 analysts
$5.00
67.20% Upside
 -77.6%
LPCN
Lipocine
 Jul 27, 2023 BUY Strong Buy
+672.5% avg upside
4 analysts
$33.00
1316.35% Upside
 +8.0%
AYTU
Aytu BioScience
 Jun 09, 2023 HOLD Strong Buy
+700.8% avg upside
7 analysts
 — +89.4%
PRQR
ProQR
 May 17, 2023 BUY Strong Buy
+516.3% avg upside
18 analysts
$4.50
138.03% Upside
 +10.9%
NOVN
Novan
 Dec 02, 2022 BUY Buy
6 analysts
$8.00
 ·
OCGN
Ocugen
 Jun 02, 2022 BUY Strong Buy
+646.0% avg upside
17 analysts
$4.50
262.96% Upside
 -80.7%
CALC
CalciMedica
 May 11, 2022 BUY Buy
+3672.8% avg upside
9 analysts
$35.00
4533.36% Upside
 ·
🔒 6 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Jennifer Kim — Frequently Asked Questions
How accurate are Jennifer Kim's stock ratings?
Based on the calls 13Foresight could measure, about 78% of Jennifer's ratings were profitable over a one-year hold, with an average return of +31.9% per rating, or +11.2% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Jennifer ranked on 13Foresight?
Jennifer Kim is currently ranked #842 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Jennifer cover?
Jennifer most recently has ratings on PGEN, BLTE, INSM, EYPT, FBIO, LPCN, AYTU, PRQR, NOVN, OCGN, CALC. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.